Room to improve rheumatoid arthritis treatment

Scimex: Medical professionals are being urged to openly discuss methotrexate for the treatment of rheumatoid arthritis (RA) to allay patient concerns and myths about its toxicity, according to the authors of a Perspective published online today in the Medical Journal of Australia.
Such concerns are informed by a range of common myths and misconceptions about the diseasemodifying anti-rheumatic drug. Rheumatologists Associate Professor Mark Arnold (Associate Dean and Head of School, University of Sydney School of rural health) and Professors Inam Haq and Jane Bleasel, (Co-Directors, Sydney University Medical Program) debunked and clarified a range of these myths and misconceptions in the MJA article.